Proinflammatory Dual Receptor T Cells in Chronic Graft-versus-Host Disease

被引:10
|
作者
Balakrishnan, Amritha [1 ]
Gloude, Nicholas [2 ]
Sasik, Roman [3 ]
Ball, Edward D. [4 ]
Morris, Gerald P. [1 ]
机构
[1] Univ Calif San Diego, Dept Pathol, 9500 Gilman Dr,MC 0612, La Jolla, CA 92093 USA
[2] Univ Calif San Diego, Dept Pediat, La Jolla, CA 92093 USA
[3] Univ Calif San Diego, Ctr Computat Biol & Bioinformat, La Jolla, CA 92093 USA
[4] Univ Calif San Diego, Dept Med, La Jolla, CA 92093 USA
关键词
T cell; Chronic graft-versus-host disease; T cell receptor; TCR; FOLLICULAR HELPER-CELLS; NEGATIVE SELECTION; DE-NOVO; TRANSPLANTATION; EXPRESSION; CD4(+); TCR; REPERTOIRE; ANTIGENS; AUTOIMMUNITY;
D O I
10.1016/j.bbmt.2017.07.016
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Defective post-transplantation thymopoiesis is associated with chronic graft-versus-host disease (GVHD), a multiorgan pathology affecting up to 80% of patients after allogeneic hematopoietic stem cell transplantation (HSCT). Previous work demonstrated that the subset of T cells expressing 2 T cell receptors (TCRs) is predisposed to alloreactivity, driving selective and disproportionate activity in acute GVHD in both mouse models and HSCT patients. Here we investigate a potential role for this pathogenic T cell subset in chronic GVHD (cGVHD). HSCT patients with cGVHD demonstrated increased numbers of dual TCR cells in circulation. These dual receptor cells had an activated phenotype, indicating an active role in cGVHD. Notably, single-cell RNA sequencing identified the increased dual TCR cells in cGVHD as predominantly expressing Tbet, indicative of a proinflammatory phenotype. These results identify dual TCR cells as specific mediators of pathogenic inflammation underlying cGVHD and highlight Tbet-driven T cell function as a potential pathway for potential therapeutic targeting. (C) 2017 American Society for Blood and Marrow Transplantation.
引用
收藏
页码:1852 / 1860
页数:9
相关论文
共 50 条
  • [21] Extracorporeal Photopheresis in Children with Chronic Graft-Versus-Host Disease
    Kozlov, Andrey
    Estrina, Maria
    Paina, Olesia
    Bykova, Tatiana
    Osipova, Anna
    Kozhokar, Polina
    Rakhmanova, Zhemal
    Solodova, Irina
    Morozova, Elena
    Alyansky, Alexander
    Kulagina, Irina
    Gevorgian, Asmik
    Dotsenko, Anna
    Moiseev, Ivan
    Chukhlovin, Alexey
    Kulagin, Alexander
    Bondarenko, Sergey
    Semenova, Elena
    Zubarovskaya, Ludmila
    PHARMACEUTICALS, 2021, 14 (08)
  • [22] Immunologic Resolution of Human Chronic Graft-versus-Host Disease
    Mahadeo, Kris M.
    Masinsin, Bernadette
    Kapoor, Neena
    Shah, Ami J.
    Abdel-Azim, Hisham
    Parkman, Robertson
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2014, 20 (10) : 1508 - 1515
  • [23] Evolving Therapeutic Options for Chronic Graft-versus-Host Disease
    Gonzalez, Rebecca M.
    Pidala, Joseph
    PHARMACOTHERAPY, 2020, 40 (08): : 756 - 772
  • [24] Therapeutic effects of hydrogen on chronic graft-versus-host disease
    Qian, Liren
    Liu, Xiaopeng
    Shen, Jianliang
    Zhao, Defeng
    Yin, Wenjie
    JOURNAL OF CELLULAR AND MOLECULAR MEDICINE, 2017, 21 (10) : 2627 - 2630
  • [25] The role of regulatory T cells in graft-versus-host disease management
    Whangbo, Jennifer S.
    Antin, Joseph H.
    Koreth, John
    EXPERT REVIEW OF HEMATOLOGY, 2020, 13 (02) : 141 - 154
  • [26] Therapeutic use of regulatory T cells for graft-versus-host disease
    Elias, Shlomo
    Rudensky, Alexander Y.
    BRITISH JOURNAL OF HAEMATOLOGY, 2019, 187 (01) : 25 - 38
  • [27] MicroRNA serum profiles and chronic graft-versus-host disease
    Reikvarn, Hakon
    Vo, Anh Khoi
    Johansen, Silje
    Hemsing, Anette Lodvir
    Solheim, Magne Haugland
    Mosevoll, Knut Anders
    Tvedt, Tor Henrik Anderson
    Haifield, Kimberley Joanne
    BLOOD ADVANCES, 2022, 6 (18) : 5295 - 5306
  • [28] Cutting Edge: Highly Alloreactive Dual TCR T Cells Play a Dominant Role in Graft-versus-Host Disease
    Morris, Gerald P.
    Adlen, Paul M.
    JOURNAL OF IMMUNOLOGY, 2009, 182 (11) : 6639 - 6643
  • [29] Anti-Angiotensin Type 1 Receptor Antibodies in Chronic Graft-Versus-Host Disease
    Chiron, Andrada
    Bouaziz, Jean-David
    Carmagnat, Maryvonnick
    de Latour, Regis Peffault
    Lafaurie-Bergeron, Anne
    Robin, Marie
    Xhaard, Alienor
    Toubert, Antoine
    Charron, Dominique
    Guigue, Nicolas
    Socie, Gerard
    Bengoufa, Djaouida
    TRANSPLANTATION, 2014, 98 (04) : 470 - 474
  • [30] IL-39 promotes chronic graft-versus-host disease by increasing T and B Cell pathogenicity
    Lv, Kangkang
    Hu, Bo
    Xu, Mingzhu
    Wan, Li
    Jin, Ziqi
    Xu, Mimi
    Du, Yuanyuan
    Ma, Kunpeng
    Lv, Quansheng
    Xu, Yang
    Lei, Lei
    Gong, Huanle
    Liu, Haiyan
    Wu, Depei
    Liu, Yuejun
    EXPERIMENTAL HEMATOLOGY & ONCOLOGY, 2022, 11 (01)